Summary
[Yue Wannianqing: Kumu injection has not yet entered the clinical trial stage]Yue Wannianqing (301111.SZ) stated on the investor interaction platform on December 17 that the company’s Kumu injection is the first variety of the original research and has the effects of clearing heat, detoxifying and anti-inflammatory It is used to treat colds, upper respiratory tract infections, acute tonsillitis, enteritis, bacillary dysentery and other diseases. At present, the experimental results are only theoretical studies and have not yet entered the stage of clinical trials. (Daily Economic News)
Every time through the AI Express, some investors ask questions on the investor interactive platform: GuangdongevergreenPharmaceutical Co., Ltd. and Qingdao Marine Biomedical Research Institute have established a cooperation, willevergreenIts gold-brand sterilized antiviral drug Kumu injection was added to the new coronavirus effect screening experiment of the State Key Laboratory. “Of the 28 components of Kumu injection, 10 may have anti-coronavirus effects. Hello, Secretary Dong! Is your product “Kumu injection” an original product? May I ask” Kumu injection may have anti-coronavirus effects. What is the current situation of anti-coronavirus?
Guangdongevergreen(301111.SZ) stated on the investor interaction platform on December 17 that the company’s bitter wood injection is the first variety of the original research, which has the effects of clearing heat, detoxification, and anti-inflammatory. For diseases such as bacillary dysentery, the results of this experiment are only theoretical research and have not yet entered the stage of clinical trials.
(Source: Daily Economic News)
.